Administration of HIV-specific T Cells to HIV+ Patients Receiving High Dose Chemotherapy Followed by Autologous Stem Cell Rescue - Auto -RESIST BMT CTN 1903
Latest Information Update: 27 Sep 2024
At a glance
- Drugs Busulfan (Primary)
- Indications Burkitt's lymphoma; Diffuse large B cell lymphoma; Hodgkin's disease; Primary-Effusion-Lymphoma
- Focus Therapeutic Use
- Acronyms Auto -RESIST; BMT CTN 1903
- 19 Sep 2024 Status changed from recruiting to active, no longer recruiting.
- 28 Oct 2021 Status changed from not yet recruiting to recruiting.
- 07 Sep 2021 Planned initiation date changed from 1 Aug 2021 to 1 Oct 2021.